LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q3 2023 Earnings Conference Call November 1, 2023 5:00 PM ET Company Participants Joseph Pellegrino - Chief Financial Officer George LeMaitre - Chief Executive Officer David Roberts - President Conference Call Participants Brooks O’Neil - Lake Street Capital Markets LLC Michael Petusky - Barrington Research Associates, Inc. James Sidoti - Sidoti & Company LLC Suraj Kalia - Oppenheimer & Co. Inc. Michael Sarcone - Jefferies Group LLC Scott Henry - ROTH Capital Partners, ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 001-33092 LEMAITRE VASCULAR, INC. (Exact name of registrant as specified in its charter) Delaware 04-2825458 (Sta ...

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q2 2023 Earnings Conference Call August 1, 2023 5:00 PM ET Company Participants Joseph Pellegrino - Chief Financial Officer David Roberts - President Conference Call Participants Brett Fishbin - KeyBanc Capital Markets Inc. Aaron Wukmir - Lake Street Capital Markets Michael Petusky - Barrington Research Associates, Inc. Operator Welcome to the LeMaitre Vascular Q2 2023 Financial Results Conference Call. As a reminder, today’s call is being recorded. At this time, I woul ...

FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 For the quarterly period ended March 31, 2023 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 001-33092 LEMAITRE VASCULAR, INC. (Exact name of registrant as specified in its charter) Delaware 04-2825458 (St ...

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q1 2023 Earnings Conference Call May 2, 2023 5:00 PM ET Company Participants Joseph Pellegrino - Chief Financial Officer George LeMaitre - Chairman and Chief Executive Officer David Roberts - President Conference Call Participants Brett Fishbin - KeyBanc Capital Markets Inc. Frederick Wise - Stifel, Nicolaus & Company, Inc. Michael Petusky - Barrington Research Associates, Inc. Scott Henry - ROTH Capital Partners Operator Welcome to the LeMaitre Vascular Q1 2023 Financi ...

2,022 Net income as reported $22,943 $17,934 $ Interest (income) expense, net (629) 1,103 (986) Amortization and depreciation expense 4,324 5,416 8,224 9,475 9,433 Provision for income taxes 5,501 3,745 6,136 7,380 6,854 EBITDA $32,139 $26,397 $45,784 $35,937 LEMAITRE VASCULAR, INC. (NASDAQ: LMAT) NON-GAAP FINANCIAL MEASURES (amounts in thousands) (unaudited) $ 26,829 3,107 ହ 29,936 $ 0.93 0.14 $ 1.07 Reconciliation between GAAP and Non-GAAP EBITDA a LeMaitre® LMAT Investor Presentation YEARS 1983-2023 $26, ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 001-33092 LEMAITRE VASCULAR, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction ...

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q4 2022 Earnings Conference Call February 23, 2023 5:00 PM ET Company Participants J.J. Pellegrino - Chief Financial Officer George LeMaitre - Chairman and Chief Executive Officer Dave Roberts - President Conference Call Participants Matthew Mishan - KeyBanc Michael Petusky - Barrington Research Brooks O’Neil - Lake Street Capital Jim Sidoti - Sidoti Operator Welcome to LeMaitre Vascular Q4 2022 Financial Results Conference Call. As a reminder, today’s call is being rec ...

Millions Diversified Portfolio of Medical Devices Used by Vascular Surgeons Approved Submitted YEARS Forward-Looking Statements LMAT Investor Presentation Disclaimers This document contains certain forward-looking statements, within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties. Actual results and events may differ significantly from results and events described in forwardlooking statements. Factors that might cause or contribute to such diffe ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 001-33092 LEMAITRE VASCULAR, INC. (Exact name of registrant as specified in its charter) Delaware 04-2825458 ...